Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials click here
Monday, May 2, 2011
AAPCHO Releases New Hepatitis B Product Series
The three-part series, entitled B Activated Resource Guide: Increasing Hepatitis B Awareness, Prevention, and Management in Asian American, Native Hawaiian, and Pacific Islander Communities, was designed to give individuals and organizations the skills and knowledge necessary to develop programs and conduct hepatitis B-related policy and media activities.
The product consists of a compendium highlighting a half-dozen successful hepatitis B programs for AA&NHOPIs; a needs assessment of current hepatitis B activities and programs conducted at community health centers, and medical providers’ perceptions of hepatitis B and AA&NHOPIs; and an advocacy toolkit of information and resources to help individuals outreach to policymakers and the media.
“Hepatitis B unfortunately is still a health disparity in our community, despite the availability of a safe and effective vaccine,” said Jeffrey Caballero, executive director at AAPCHO. “In order to make inroads, we need to continue educating policymakers, the media and federal and local agencies, and developing culturally and linguistically appropriate programs to eradicate this disease. It is our hope that this series gives individuals the tools they need to do so.”
The series comes as federal agencies announce their plans to address this disease. AAPCHO issued key recommendations that helped place hepatitis B as a priority on the Department of Health & Human Services’ plan to address AA&NHOPI health.
Hepatitis B continues to disproportionately impact AA&NHOPI populations. Approximately 50% of people with chronic hepatitis B in the U.S. are AA&NHOPI, and one in ten AA&NHOPIs suffer from chronic hepatitis B. An estimated 65% of those chronically infected are unaware of it and are at risk of transmitting the infection and of progressing to liver disease or developing liver cancer.
The product series is available on AAPCHO’s website at hepatitisBseries.aapcho.org.
AAPCHO is a national association of 29 community health organizations dedicated to promoting advocacy, collaboration, and leadership that improves the health status and access of Asian Americans, Native Americans, and other Pacific Islanders in the United States. For more information on AAPCHO and its Guiding Principles and Values, please visit www.aapcho.org. AAPCHO can also be found on Facebook at www.facebook.com/aapcho.